Drug classification
Get active in drug policy
Hot topics: alcohol | drug law review The Government and its agencies, Parliament and other organisations often seek comment and input into drug policy issues. This might be in the form of consultations or inviting submissions to select committees, or seeking expert comment on draft policies.
22 August 2007 | Party pill ban bill introduced
Associate Minister of Health and Leader of the Progressive Party Jim Anderton has announced the introduction of the Misuse of Drugs (Classification of BZP) Amendment Bill to in the House today.
Reclassification of bzp (Submission)
In 2004 Mr Anderton asked the Expert Advisory Committee on Drugs (EACD) to review recent New Zealand research on benzylpiperazine (BZP), the main ingredient in most party pills. The official EACD report was released by Mr Anderton on 20 December 2006. It recommended BZP be classified as C1 under the Misuse of Drugs Act alongside drugs such as cannabis. It is illegal to possess or sell Class C drugs.
Health Select Committee report on Misuse of Drugs Act May 2005
Misuse of Drugs Amendment Bill (No 3) (186-2) and Supplementary Order Paper 298 (23 May 2005)The bill as introduced amends two main areas of the Misuse of Drugs Act 1975 (the principal Act) and the Misuse of Drugs Amendment Act 1978 (the amendment Act). The bill allows presumption of supply matters to be amended by Order in Council, subject to an affirmative resolution procedure. It also amends the presumption of supply quantity for methamphetamine, and adds a Ministry of Justice official to the membership of the Expert Advisory Committee on Drugs.
Health Select Committee report on drug classification changes April 2003
Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (9 April 2003)The Health Committee has examined the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 and recommends that the related notice of motion be approved.
Summary of research on party pills
This paper summarises recent research findings on BZP/party pills, and outlines the current legislative status of BZP. It is being made available to assist organisations or people wanting to make submissions on the proposal to reclassify BZP and its analogues.
Expert Advisory Committee on Drugs (EACD)
The Misuse of Drugs Amendment Act 2000 (the Act) established the Expert Advisory Committee on Drugs (EACD) to provide expert advice to the Minister of Health regarding drug classification issues.
Health Select Committee report on ephedrine and pseudoephedrine December 2003
Misuse of Drugs (Classification of Ephedrine and Pseudoephedrine) Order 2003 (17 December 2003)The Misuse of Drugs (Classification of Ephedrine and Pseudoephedrine) Order 2003:classifies pseudoephedrine preparations containing not more than 60 milligrams a dosage unit as a Class C3 drug
